导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 13.24% | 178/268 |
| 近一周 | -0.50% | 293/293 |
| 近一月 | -1.14% | 175/291 |
| 近一季 | 2.93% | 44/283 |
| 近半年 | 8.89% | 232/278 |
| 近一年 | 13.87% | 127/267 |
| 近两年 | 22.73% | 83/244 |
| 近三年 | 13.62% | 54/179 |
| 成立以来 | 58.31% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-0.04% 257/287 |
5.05% 10/293 |
6.19% 264/296 |
- - |
| 2024 | 8.10% 25/287 |
1.16% 25/290 |
2.31% 4/295 |
0.07% 287/292 |
4.37% 8/287 |
| 2023 | -4.93% 53/281 |
3.43% 49/236 |
-3.29% 190/256 |
-3.26% 86/271 |
-1.74% 49/281 |
| 2022 | -13.01% 60/228 |
-9.32% 56/121 |
3.62% 69/141 |
-6.51% 68/157 |
-0.98% 105/228 |
| 2021 | 4.30% 52/116 |
-1.54% 568/1745 |
5.93% 1311/2232 |
-0.98% 759/2560 |
0.99% 87/116 |
| 2020 | 35.30% 10/86 |
-1.54% 502/1036 |
17.41% 799/1256 |
8.09% 827/1472 |
8.29% 1203/1690 |
| 2019 | - - |
- - |
-1.70% 1919/3201 |
4.64% 531/939 |
6.59% 684/1014 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 创金合信全球医药生物股票发起(QDII)C | 1.8141 | 37.76% |
| 易方达标普生物科技人民币A | 1.7328 | 28.02% |
| 永赢先锋半导体智选混合发起C | 1.2684 | 26.99% |
| 银华集成电路混合A | 1.4951 | 23.93% |
| 华商致远回报混合A | 1.6291 | 23.20% |
| 华夏中证半导体材料设备主题ETF | 1.5851 | 22.62% |
| 天弘中证半导体材料设备主题指数发起C | 1.7561 | 21.34% |
| 诺安优化配置混合A | 2.5072 | 17.29% |
| 东方低碳经济混合C | 1.2657 | 17.06% |
| 广发生物科技指数美元(QDII)A | 0.2092 | 16.76% |
| 南方合顺多资产(FOF)C VS. () |